Drugs & Medical Device Defect Resources
Accutane
Baush & Lomb
Bextra
- FDA asks Pfizer to remove Bextra(R) from the Market
- Bextra FAQ
- Treatment of severe drug reactions Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis and Hypersensitivity syndrome
Celebrex
- Celebrex Label
- Celebrex Health Care Information Sheet
- Celebrex Patient Information Sheet
- FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex
Crestor & Rhabdomylosis
Fen-Phen & PPH
Fosamax
Gadolinium
Defective Medical Devices
Ketek
- Important Info About Ketek
- FDA Announces Label and Indication Changes for the Antibiotic Ketek
- Ketek Description and Warning
- Ketek Medication Guide
- Telithromycin (marketed as Ketek) Information
- FDA Public Health Advisory
- Questions and Answers on Telithromycin (marketed as Ketek)
Non-Steroidal Anti-Inflammitory Drugs (NSAID's)
- FDA List of all Prescription and OTC NSAID's
- FDA NSAID medication guide
- FDA proposed revised package insert
- FDA supplemental letter adding risks of SJS to label
Ortho Evra
Trasylol (Aprotinin)
Vioxx
- FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product
- David Graham memorandum on the safety of Vioxx
- Merck Found Liable in First Vioxx Trial
Zyprexa